Exiqon

company

About

Exiqon operates in two business areas, Life Sciences and Diagnostics.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$20M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics,Life Science,Medical
Founded date
Jan 1, 1995
Number Of Employee
51 - 100
Operating Status
Active

Exiqon operates in two business areas: Life Sciences and Diagnostics.

Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other diseases.

Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20M
Exiqon has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2005 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 3, 2005 Series Unknown $20M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Exiqon is funded by 1 investors. Biofund are the most recent investors.
Investor Name Lead Investor Funding Round
Biofund Series Unknown